Phenex Pharmaceuticals
Latest round
- Series D
Last raised
- Oct 2012
Total raised
- $19M
Investors
- 6
About Phenex Pharmaceuticals
Founded in 2002 and headquartered in Ludwigshafen, Germany, Phenex Pharmaceuticals AG specializes in developing treatments for oncology and autoimmune diseases.Phenex Pharmaceuticals AG specializes in the development of innovative treatments aimed at addressing significant unmet medical needs within the realms of oncology and autoimmune diseases. The company's core product offerings revolve around novel pharmaceuticals that target specific molecular pathways to enhance therapeutic efficacy and minimize side effects. Notable products are designed to modulate immune responses or inhibit tumor growth, thereby providing targeted solutions for patients suffering from chronic conditions. The end users primarily include healthcare providers and patients in regions such as North America and Europe, where Phenex's products are actively marketed.Phenex Pharmaceuticals AG generates revenue through strategic collaborations and partnerships with other pharmaceutical entities, which facilitate the development and commercialization of its proprietary products. The company typically engages in B2B transactions, collaborating with larger biotech firms to leverage their distribution networks and market reach. A significant portion of revenue may also stem from milestone payments associated with the progression of clinical trials and regulatory approvals of its flagship products. The revenue model includes structured agreements that allow for co-development and profit-sharing, ensuring mutual benefits for Phenex and its partners. The company plans to expand its product pipeline by introducing new treatments targeting specific cancer types and chronic autoimmune conditions, with anticipated launches in the next few years. Additionally, Phenex seeks to enter new markets across Asia and South America by 2025, leveraging its strategic partnerships to establish a strong presence.
Who invested in Phenex Pharmaceuticals
6 investors across 3 rounds
See all investors in Phenex Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Phenex Pharmaceuticals
Who invested in Phenex Pharmaceuticals?
Phenex Pharmaceuticals has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Phenex Pharmaceuticals raised?
Phenex Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Phenex Pharmaceuticals last raise money?
Phenex Pharmaceuticals's most recent round on record is a Series D, in Oct 2012.
What does Phenex Pharmaceuticals do?
Founded in 2002 and headquartered in Ludwigshafen, Germany, Phenex Pharmaceuticals AG specializes in developing treatments for oncology and autoimmune diseases.
Where is Phenex Pharmaceuticals headquartered?
Phenex Pharmaceuticals is headquartered in Ludwigshafen, Germany.
Which VCs invest in companies like Phenex Pharmaceuticals?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Phenex Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Phenex Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.